Browse studies

Find your next paid study

14 recruiting studies matching your filters

A Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants With COPD

This is a Phase 2 study of the efficacy, safety, tolerability and pharmacokinetics of two doses of EXPD-101 in participants with COPD. Study participants will …

Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $8,750

Expedition Therapeutics, IncNCT07684820

Phase 4

Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD

Multi-site, randomized controlled trial to determine whether patients who report NO symptomatic benefit with their maintenance hand-held inhaler(s), benefit up…

COPD (Chronic Obstructive Pulmonary Disease)Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $6,250

COPD FoundationNCT07816835

Phase 2

A Multicentre, Parallel-group, Phase IIb, Randomised, Double-blind, Placebo-controlled, 3-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (PRESTO)

This Phase IIb dose-ranging study will evaluate the efficacy and safety of 2 different doses of AZD6793 compared with placebo tablets in participants with mode…

Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $7,500

AstraZenecaNCT07082738

Phase 2

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD (COPD-OMA)

This research is being done to test if a drug called omalizumab can help people with Chronic Obstructive Pulmonary Disease (COPD) and allergies. Each particip…

Chronic Obstructive Pulmonary Disease (COPD)Allergies

Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT07059091

Phase 3

A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Mo…

Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $7,500

AstraZenecaNCT06883305

Phase 3

A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Mo…

Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $7,500

AstraZenecaNCT06878261

Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities: A Pilot Study of the Patient Priorities Care Approach at Cooper Green Mercy Health Services Authority (PPC-HEART)

This is formative evaluation trial guided by the Values Clarification Theory25 and the Cultural Values Theory26, with specific aims to: Aim 1. Develop a cultur…

CardiovascularComorbidityDiabetes+4 more

Estimated

~$10 – $750

University of Alabama at BirminghamNCT07748858

Phase 3

Multi-Center Clean Air Randomized Controlled Trial in COPD

This is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air q…

Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $6,250

JHSPH Center for Clinical TrialsNCT06376994

Examining the Role of Functional Social Support Subtypes for Self-Management Capacity Among Individuals With COPD

This observational study aims to examine how different types of functional social support (emotional/informational, tangible, affectionate, and positive social…

Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $750

Medical University of South CarolinaNCT07353034

Temple Health Chest Initiative (THCI 2.0) - Lung Cancer Screening Project With COPD Detection

Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading caus…

Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $750

Temple UniversityNCT06933758

Phase 1

Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations

The purpose of this study is to investigate the safety and tolerability of Metformin and how it changes blood markers associated with aging in persons who have…

Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $6,250

Duke UniversityNCT07275359

Observational

WearME-Pro Phase II: Remote Use Usability and Longitudinal Validation Study (Patch Form Factor)

This Phase II investigation evaluates the safety, usability, and clinical performance of the WearME-Pro patch system for remote monitoring of adults with COPD …

Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $6,250

LASARRUS Clinic and Research CenterNCT07430605